Woodline Partners LP

Position in ZVRA — Zevra Therapeutics, Inc.

CIK 1784547 San Francisco, CA

Position in ZVRA

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$32,162,788

+$1,243,226 QoQ

Shares Held

3,450,943

+0.0% QoQ

Ownership

5.84%

of shares outstanding

% of Portfolio

0.12%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Woodline Partners LP holds $3,424,016,489 across 189 Biotechnology names. ZVRA ranks #32 (0.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc.	2,506,570	$243,763,932
2	TNGX	Tango Therapeutics, Inc.	8,000,013	$167,360,271
3	PTGX	Protagonist Therapeutics, Inc	1,414,173	$149,053,834
4	QNCX	Quince Therapeutics, Inc.	5,200,000	$105,040,000
5	RCUS	Arcus Biosciences, Inc.	3,777,798	$81,600,436
6	ALNY	Alnylam Pharmaceuticals, Inc.	243,883	$80,693,568
7	SRRK	Scholar Rock Holding Corp	1,500,470	$73,763,105
8	RYTM	Rhythm Pharmaceuticals, Inc.	758,891	$66,000,750

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$32,162,788	3,450,943	+0.0%	Shares	Sole	2026-05-15
2025-12-31	$30,919,562	3,450,844	-0.7%	Shares	Sole	2026-02-17
2025-09-30	$33,058,119	3,476,143	-24.7%	Shares	Sole	2025-11-14
2025-06-30	$40,664,105	4,615,676	+0.0%	Shares	Sole	2025-08-14
2025-03-31	$34,571,031	4,615,625	+11.5%	Shares	Sole	2025-05-15
2024-12-31	$34,524,205	4,139,593	+2.2%	Shares	Sole	2025-02-14
2024-09-30	$28,097,651	4,048,653	+252.8%	Shares	Sole	2024-11-14
2024-06-30	$5,623,156	1,147,583	+13.7%	Shares	Sole	2024-08-14
2024-03-31	$5,855,778	1,009,617	—	Shares	Sole	2024-05-15
No filing history on record for this holder in this stock.